2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow TKIs: new trials by email Literature Review of TKIs trials Research Report on TKIs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma Toripalimab, Axitinib - Neoadjuvant Therapy, Advanced Cancer | Phase 2 | Unknown | West China Hospital | 40 | 2020-06-01 | 2020-05-13 |
| TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia TKIs - Philadelphia Chromosome Positive Acute Lymphocytic Leukemia, Stem Cell Transplantation | Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 80 | 2013-06-01 | 2017-11-08 |
Kidney Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasm, Residual (1) · Philadelphia Chromosome (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Nanfang Hospital, Southern Medical University (1) · West China Hospital (1)
China (1)
Qifa Liu, MD (1)